105 related articles for article (PubMed ID: 15628665)
1. Ligand binding characteristics of the human serotonin1A receptor heterologously expressed in CHO cells.
Kalipatnapu S; Pucadyil TJ; Harikumar KG; Chattopadhyay A
Biosci Rep; 2004 Apr; 24(2):101-15. PubMed ID: 15628665
[TBL] [Abstract][Full Text] [Related]
2. Role of disulfides and sulfhydryl groups in agonist and antagonist binding in serotonin1A receptors from bovine hippocampus.
Harikumar KG; John PT; Chattopadhyay A
Cell Mol Neurobiol; 2000 Dec; 20(6):665-81. PubMed ID: 11100975
[TBL] [Abstract][Full Text] [Related]
3. G-protein-dependent cell surface dynamics of the human serotonin1A receptor tagged to yellow fluorescent protein.
Pucadyil TJ; Kalipatnapu S; Harikumar KG; Rangaraj N; Karnik SS; Chattopadhyay A
Biochemistry; 2004 Dec; 43(50):15852-62. PubMed ID: 15595840
[TBL] [Abstract][Full Text] [Related]
4. Prolonged treatment with ligands affects ligand binding to the human serotonin(1A) receptor in Chinese hamster ovary cells.
Pucadyil TJ; Jafurulla M; Chattopadhyay A
Cell Mol Neurobiol; 2006 May; 26(3):247-57. PubMed ID: 16767512
[TBL] [Abstract][Full Text] [Related]
5. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
6. Differential discrimination of G-protein coupling of serotonin(1A) receptors from bovine hippocampus by an agonist and an antagonist.
Harikumar KG; Chattopadhyay A
FEBS Lett; 1999 Sep; 457(3):389-92. PubMed ID: 10471814
[TBL] [Abstract][Full Text] [Related]
7. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
8. Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.
Harikumar KG; Chattopadhyay A
Cell Mol Neurobiol; 1998 Oct; 18(5):535-53. PubMed ID: 9777253
[TBL] [Abstract][Full Text] [Related]
9. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Millan MJ
Neuropharmacology; 1997; 36(4-5):451-9. PubMed ID: 9225269
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus.
Pucadyil TJ; Chattopadhyay A
Biochim Biophys Acta; 2004 May; 1663(1-2):188-200. PubMed ID: 15157621
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
Barrondo S; Sallés J
Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.
Defraiteur C; Plenevaux A; Scuvée-Moreau J; Rouchet N; Goblet D; Luxen A; Seutin V
Br J Pharmacol; 2007 Nov; 152(6):952-8. PubMed ID: 17704821
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic studies of 5-HT1A-receptor-stimulated [35S]GTPgammaS-binding responses in the human and monkey brain.
Dupuis DS; Pauwels PJ; Radu D; Hall H
Eur J Neurosci; 1999 May; 11(5):1809-17. PubMed ID: 10215933
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
16. Binding properties of dipropyltryptamine at the human 5-HT1a receptor.
Thiagaraj HV; Russo EB; Burnett A; Goldstein E; Thompson CM; Parker KK
Pharmacology; 2005 Jul; 74(4):193-9. PubMed ID: 15886504
[TBL] [Abstract][Full Text] [Related]
17. Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors.
Jafurulla M; Pucadyil TJ; Chattopadhyay A
Biochim Biophys Acta; 2008 Oct; 1778(10):2022-5. PubMed ID: 18675780
[TBL] [Abstract][Full Text] [Related]
18. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
19. Role of cholesterol in ligand binding and G-protein coupling of serotonin1A receptors solubilized from bovine hippocampus.
Chattopadhyay A; Jafurulla M; Kalipatnapu S; Pucadyil TJ; Harikumar KG
Biochem Biophys Res Commun; 2005 Feb; 327(4):1036-41. PubMed ID: 15652500
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids modulate the function of human serotonin
Jafurulla M; Bandari S; Pucadyil TJ; Chattopadhyay A
Biochim Biophys Acta Biomembr; 2017 Apr; 1859(4):598-604. PubMed ID: 27984018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
